We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
-6.7%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$217M
AUM Growth
–
Cap. Flow
+$232M
Cap. Flow %
106.66%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ICVX
Icosavax, Inc. Common Stock
ICVX
+$90.7M
2
JSPR icon
Jasper Therapeutics
JSPR
+$54.8M
3
TRML
Tourmaline Bio
TRML
+$43.4M
4
VTYX
Ventyx Biosciences
VTYX
+$17.3M
5
ELEV
Elevation Oncology
ELEV
+$16.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
$80.3M 36.96%
+3,510,228
New +$90.7M
JSPR icon
2
Jasper Therapeutics
JSPR
$22.4M
$45.9M 21.14%
+585,298
New +$54.8M
TRML
3
DELISTED
Tourmaline Bio
TRML
$44.8M 20.63%
+293,261
New +$43.4M
VTYX
4
DELISTED
Ventyx Biosciences
VTYX
$18.1M 8.32%
+910,306
New +$17.3M
ELEV
5
DELISTED
Elevation Oncology
ELEV
$14.3M 6.57%
+2,370,142
New +$16.4M
KZR
6
DELISTED
Kezar Life Sciences
KZR
$13.9M 6.38%
+82,871
New +$9.36M

Similar funds

CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
LAM
Lingohr Asset Management Duesseldorf, Germany $57.3M AUM 35.27% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Qiming U.S. Ventures Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Qiming U.S. Ventures Management, which disclosed 6 positions worth $217M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Icosavax, Inc. Common Stock: 3,510,228 shares worth $80.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Qiming U.S. Ventures Management's largest Q4 2021 buy was Icosavax, Inc. Common Stock: 3,510,228 shares worth $80.3M.
  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $217M portfolio in Q4 2021.
  • Qiming U.S. Ventures Management disclosed 6 positions in Q4 2021, its first 13F filing on record.

Based on Qiming U.S. Ventures Management's 13F filing for Q4 2021, filed 14 Feb 2022.